Iovance Biotherapeutics Inc (IOVA) Stock: Exploring a Year of Highs, Lows, and Trading Volume

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Iovance Biotherapeutics Inc’s current trading price is -5.43% away from its 52-week high, while its distance from the 52-week low is 203.74%. The stock’s price range over this period has fluctuated between $3.21 and $10.31. The company, operating within the financial sector, had a trading volume of approximately 3.91 million for the day, which was noticeably higher than the average daily share volume of 0.97 over the last 3 months.

Iovance Biotherapeutics Inc experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $10.31 on 01/09/24, while the lowest price for the same period was registered at $3.21 on 10/19/23.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Iovance Biotherapeutics Inc (IOVA) has experienced a quarterly rise of 146.84% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.50B.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 6.09, with a change in price of +4.26. Similarly, Iovance Biotherapeutics Inc recorded 6,890,576 in trading volume during the last 100 days, posting a change of +78.36%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for IOVA stands at 0.12. Similarly, the long-term debt-to-equity ratio is also 0.10.

IOVA Stock Stochastic Average

Today’s raw stochastic average for Iovance Biotherapeutics Inc over the last 50 days is 86.26%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 89.50%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 76.74% and 56.97%, respectively.

IOVA Stock Price Performance Analysis

Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Year to date metric has recorded a gain of 19.93%.However, over the last six months, we can see a weaker performance of 38.10%. Over the last 30 days, the price of IOVA has fallen by 6.56%. And in the last five days, it has surged by 23.11%.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts